|
periodontal disease |
5 |
|
biological therapy |
3 |
|
host microbial interactions |
3 |
|
microbiome |
3 |
|
nonsurgical therapy |
3 |
|
periodontitis |
3 |
|
acute periodontal conditions |
2 |
|
antibiotic therapy |
2 |
|
antibiotics |
2 |
|
dental implants |
2 |
|
diabetes mellitus |
2 |
|
endo-periodontal lesion |
2 |
|
necrotizing gingivitis |
2 |
|
necrotizing periodontitis |
2 |
|
peri-implantitis |
2 |
|
periimplantitis |
2 |
|
periodontal abscess |
2 |
|
periodontal therapy |
2 |
|
a. actinomycetemcomitans |
1 |
|
abrasion |
1 |
|
acetylsalicylic acid |
1 |
|
actinobacillus actinomycetemcomitans |
1 |
|
adjunctive therapy |
1 |
|
air polishing |
1 |
|
air polishing device |
1 |
|
allografts |
1 |
|
alveolar ridge augmentation |
1 |
|
amoxicillin |
1 |
|
amoxicillin/therapeutic use |
1 |
|
amstar |
1 |
|
analysis |
1 |
|
anti-bacterial agents |
1 |
|
antibiotic prophylaxis |
1 |
|
antibiotic susceptibility |
1 |
|
antibiotics, antibacterial/therapeutic use |
1 |
|
antibiotics, combination/therapeutic use |
1 |
|
antibody |
1 |
|
antigen |
1 |
|
antimicrobial |
1 |
|
antimicrobial irrigation |
1 |
|
apoptosis |
1 |
|
autografts |
1 |
|
bacteria |
1 |
|
bacteriotherapy |
1 |
|
bacteroides intermedius |
1 |
|
biofilm |
1 |
|
biofilms |
1 |
|
bleeding on probing |
1 |
|
bone density |
1 |
|
bone regeneration |
1 |
|
bone, demineralized |
1 |
|
bone, freeze-dried |
1 |
|
calculus removal |
1 |
|
campylobacter rectus |
1 |
|
caries |
1 |
|
caspases |
1 |
|
cathepsin g |
1 |
|
caucasian |
1 |
|
cavitation |
1 |
|
cd95 |
1 |
|
chlorhexidine digluconate |
1 |
|
chronic periodontitis |
1 |
|
clonal infection |
1 |
|
collagenase gene |
1 |
|
colonization |
1 |
|
compromised |
1 |
|
controlled topical application |
1 |
|
cost-benefit analyses |
1 |
|
cost-benefit analysis |
1 |
|
cost-effectiveness |
1 |
|
cost-effectiveness analyses |
1 |
|
cost-effectiveness analysis |
1 |
|
cost-minimization analyses |
1 |
|
cost-utility analysis |
1 |
|
cyclosporin |
1 |
|
cysts |
1 |
|
damage |
1 |
|
debridement |
1 |
|
defensin |
1 |
|
dental instruments |
1 |
|
dental polishing |
1 |
|
dental scaling |
1 |
|
dental-scaling |
1 |
|
disc diffusion |
1 |
|
disease progression |
1 |
|
dna fingerprinting |
1 |
|
drug therapy |
1 |
|
dynamics |
1 |
|
early‐onset periodontitis |
1 |
|
economic evaluation |
1 |
|
edentulism |
1 |
|
eikenella corrodens |
1 |
|
elastase |
1 |
|
endosseous implant |
1 |
|
epidemiology |
1 |
|
fibroblast heterogeneity |
1 |
|
fima genotype |
1 |
|
follow-up studies |
1 |
|
full-mouth glycine powder air polishing |
1 |
|
genetics |
1 |
|
gingipain |
1 |
|
gingival blood |
1 |
|
gingival crevicular fluid |
1 |
|
gingival overgrowth |
1 |
|
grade |
1 |
|
grafts, bone |
1 |
|
guided tissue regeneration |
1 |
|
health economics |
1 |
|
health-economy |
1 |
|
heterogeneity |
1 |
|
histology |
1 |
|
host response |
1 |
|
immune response |
1 |
|
implant success |
1 |
|
implant-supported dental prosthesis |
1 |
|
implant-supported prosthesis |
1 |
|
implants |
1 |
|
in vitro |
1 |
|
inflammatory bowel disease |
1 |
|
initial periodontal therapy |
1 |
|
kgp |
1 |
|
laser therapy |
1 |
|
maintenance |
1 |
|
meta-analysis |
1 |
|
metronidazole |
1 |
|
metronidazole/therapeutic use |
1 |
|
microbial diagnosis |
1 |
|
microbial transplant |
1 |
|
microbicidal protein |
1 |
|
microbiology |
1 |
|
moxifloxacin |
1 |
|
mucosal hyperplasia |
1 |
|
multiprotein arrays |
1 |
|
neutral serine protease |
1 |
|
non-steroidal anti-inflammatory drugs |
1 |
|
non-surgical periodontal therapy |
1 |
|
non‐steroidal anti‐inflammatory drugs |
1 |
|
orphan disease |
1 |
|
osseointegration |
1 |
|
outer membrane protein |
1 |
|
papillon-lefèvre syndrome |
1 |
|
parp |
1 |
|
patient reported outcome measures |
1 |
|
patient-reported outcome measurements |
1 |
|
peptostreptococcus micros |
1 |
|
periimplant mucositis |
1 |
|
periodontal attachment loss/prevention and control |
1 |
|
periodontal bacteria |
1 |
|
periodontal disease therapy predictors smoking treatment outcome |
1 |
|
periodontal diseases |
1 |
|
periodontal diseases/epidemiology |
1 |
|
periodontal diseases/microbiology |
1 |
|
periodontal diseases/therapy |
1 |
|
periodontal health |
1 |
|
periodontal pathogens |
1 |
|
periodontal regeneration |
1 |
|
periodontitis therapy |
1 |
|
periodontitis-therapy |
1 |
|
periodontitis/therapy |
1 |
|
periodontrtis |
1 |
|
piezoelectric |
1 |
|
plaque removal |
1 |
|
plasminogen |
1 |
|
polylactic acid |
1 |
|
polymerase chain reaction |
1 |
|
polymorphonuclear leukocyte |
1 |
|
porphyromonas gingivalis |
1 |
|
powder emission |
1 |
|
prepubertal periodontitis |
1 |
|
prevalence |
1 |
|
prevention |
1 |
|
primary stability |
1 |
|
prognosis |
1 |
|
prognostic model |
1 |
|
progression |
1 |
|
protease |
1 |
|
protease inhibitor |
1 |
|
prtc |
1 |
|
pulsed‐field gel electrophoresis |
1 |
|
quantification |
1 |
|
randomized clinical trial |
1 |
|
red complex |
1 |
|
red complex bacteria |
1 |
|
restriction fragment-length polymorphism |
1 |
|
rgpa |
1 |
|
rgpb |
1 |
|
risk |
1 |
|
risk factor |
1 |
|
risk factors |
1 |
|
root |
1 |
|
root damage |
1 |
|
root defects |
1 |
|
root planing |
1 |
|
root substance removal |
1 |
|
scaling |
1 |
|
scaling/instrumentation |
1 |
|
screening |
1 |
|
sequence |
1 |
|
sinus floor augmentation |
1 |
|
smoking |
1 |
|
smoking cessation |
1 |
|
soft-tissue grafts |
1 |
|
sonic scaler |
1 |
|
sonication |
1 |
|
subgingival |
1 |
|
subgingival curettage |
1 |
|
subgingival plaque removal |
1 |
|
supportive periodontal care |
1 |
|
supportive periodontal therapy |
1 |
|
supragingival irrigation |
1 |
|
systematic disease |
1 |
|
systematic review |
1 |
|
systemic |
1 |
|
temperature |
1 |
|
testing |
1 |
|
tetracycline |
1 |
|
therapy |
1 |
|
three-dimensional measurement |
1 |
|
tooth eruption |
1 |
|
tooth loss |
1 |
|
tooth root |
1 |
|
tooth survival |
1 |
|
ultrasonic scaling |
1 |
|
ultrasonication |
1 |
|
ultrasonics |
1 |
|
virulence |
1 |
|
xenografts |
1 |
|
α1-proteinase inhibitor |
1 |
